Struggle of Managing Labeling Content

In the current scenario, labeling can be in various forms like that of physical and digital as well. Controlling the content becomes difficult as it comes from several sources. All these contents do undergo safety changes thereby making the task of tracking even more difficult. Generally, during periodic review or post-marketing, clinical safety-related information changes. Manufacturers/ Sponsors try to modify the labels according to the prior approval supplement (PAS), post-marketing surveillance (PMS) details, changes being effected (CBE) and even annual reports before submitting it to the regulatory authorities. This would allow the sponsors to update the labels independently following the latest safety information and with immediate action. Organizations look forward to collaboration so that all the data is available at the source thus enabling them to keep a check on the labeling content. To ensure this control, e-labeling has already entered the market and with time it is taking up much of the space in the life science industry. The spread of e-labels has been so extensive just because a maximum portion of the information can be delivered through such e-labels and e-labels allow for an easy updating of information than the printed labels.